Intra-Cellular Therapies (ITCI) Reports Q1 Loss of $0.63/Share

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.63), versus ($0.65) reported last year.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'
• KeyBanc Reiterates Overweight Rating on Worthington Steel Inc (WS)